Physician

Srikar R Malireddy, MD

According to 2025 Medicare claims, Srikar Malireddy, MD (NPI: 1255517561) practices hematology/oncology in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 76310-1610. Malireddy is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Malireddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,437 traditional Medicare patients, billed 364,512 HCPCS/CPT codes, and received $4,324,263 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 2,363 prescription claims across 384 beneficiaries totaling $5,246,360 in drug costs, led by Revlimid (Lenalidomide). DME data shows 42 claims. Open Payments data shows 17 records totaling $442. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,231,266 to $4,324,263. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $473,481 to $5,246,360. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	643	267,869	$1,231,266
2016	1,165	388,386	$1,928,542
2017	1,461	280,583	$2,421,335
2018	1,450	392,774	$3,042,236
2019	1,549	525,380	$3,720,772
2020	1,365	406,601	$2,687,835
2021	1,384	434,385	$3,480,999
2022	1,282	402,158	$3,466,830
2023	1,406	466,296	$3,727,202
2024	1,437	364,512	$4,324,263

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	162	891	$473,481
2016	223	1,585	$840,212
2017	235	1,561	$1,071,144
2018	226	1,492	$1,083,085
2019	244	1,705	$1,937,278
2020	241	1,624	$2,481,644
2021	297	1,736	$2,959,419
2022	293	1,780	$2,535,050
2023	319	2,031	$3,117,209
2024	384	2,363	$5,246,360

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	160	$8,711
2016	22	130	$20,214
2017	N/R	36	$3,969
2018	N/R	56	$7,720
2019	N/R	132	$43,915
2020	N/R	29	$2,538
2021	N/R	88	$7,032
2022	N/R	28	$1,092
2023	N/R	24	$1,809
2024	N/R	42	$2,027

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	800	1,481	$13
80053	Blood test, comprehensive group of blood chemicals	814	2,207	$10
36415	Insertion of needle into vein for collection of blood sample	855	2,950	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	845	2,588	$8
83540	Iron level	798	1,481	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	60	1,596	$1,019,158
Pomalyst	Pomalidomide	27	749	$510,129
Xtandi	Enzalutamide	36	1,080	$448,322
Verzenio	Abemaciclib	27	756	$407,379
Jakafi	Ruxolitinib Phosphate	21	630	$358,609

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$1,019
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	17	$802
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$442	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Srikar R. Malireddy, MD?

Tedicare shows public-source Medicare data for Srikar R. Malireddy, MD (NPI 1255517561), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Srikar R. Malireddy, MD have ACO affiliation data?

Srikar R. Malireddy, MD is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Srikar R. Malireddy, MD?

Srikar R. Malireddy, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Srikar R. Malireddy, MD have Open Payments data?

Srikar R. Malireddy, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.